title: Myocardial infarction in Norway in 2013.
abstract: BACKGROUND
  The Norwegian Myocardial Infarction Registry was established in 2012 as a national quality registry. This first report from the registry presents the number of myocardial infarctions, the treatment provided and the 30-day mortality rate for myocardial infarctions admitted to Norwegian hospitals.
  
  
  METHODS
  All patients with myocardial infarction admitted to Norwegian hospitals in 2013 and recorded in the Norwegian Myocardial Infarction Registry are included. The number of myocardial infarctions, patient characteristics and their treatment are indicated for myocardial infarctions with and without ST-segment elevation on ECG (STEMI and nSTEMI). The 30-day mortality is calculated for each health region.
  
  
  RESULTS
  In 2013, a total of 13,043 myocardial infarctions in 12,336 patients were recorded in the Norwegian Myocardial Infarction Registry. Altogether 3,658 (28%) of the infarctions were classified as STEMI and 9,188 (70%) as nSTEMI. The average age at the time of the infarction was 68.1 years for men and 75.9 years for women. Percutaneous coronary intervention was performed for a total of 2,798 (77%) ST-segment elevation myocardial infarctions, whereas the corresponding number for nSTEMI was 3,179 (35%). The 30-day mortality in the entire infarction population was 10% (< 60 years: 2%, 60-69 years: 4%, 70-79 years: 9%, ≥ 80 years: 20%). We found no differences in mortality between health regions or between men and women.
  
  
  CONCLUSIONS
  This first report from the Norwegian Myocardial Infarction Registry shows that the treatment service is functioning well for most patients. Secondary prophylaxis using drug therapy and increased use of invasive examination of patients with nSTEMI appear to be areas for improvement.
authors.affiliation: Kardiologisk avdeling Hjerteseksjonen Medisinsk avdeling Sørlandet sykehus Arendal.
authors.forename: Jarle
authors.initials: J
authors.lastname: Jortveit
authors.affiliation: Kardiologisk avdeling Norsk hjerteinfarktregister St. Olavs hospital.
authors.forename: Ragna Elise Støre
authors.initials: RE
authors.lastname: Govatsmark
authors.affiliation: Kardiologisk avdeling Norsk hjerteinfarktregister St. Olavs hospital.
authors.forename: Tormod Aarlott
authors.initials: TA
authors.lastname: Digre
authors.affiliation: Kardiologisk avdeling Oslo universitetssykehus, Rikshospitalet.
authors.forename: Cecilie
authors.initials: C
authors.lastname: Risøe
authors.affiliation: Hjertemedisinsk avdeling Klinikk for medisin Helse Møre og Romsdal.
authors.forename: Torstein
authors.initials: T
authors.lastname: Hole
authors.affiliation: Hjertemedisinsk avdeling Universitetssykehuset Nord-Norge.
authors.forename: Jan
authors.initials: J
authors.lastname: Mannsverk
authors.affiliation: Hjertemedisinsk avdeling St. Olavs hospital og Norges teknisk-naturvitenskapelige universitet.
authors.forename: Stig Arild
authors.initials: SA
authors.lastname: Slørdahl
authors.affiliation: Hjertemedisinsk avdeling Oslo universitetssykehus, Ullevål.
authors.forename: Sigrun
authors.initials: S
authors.lastname: Halvorsen
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D004363:Drug Utilization / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality / Q000601:surgery; D009664:Norway / Q000453:epidemiology; D010343:Patient Admission / Q000706:statistics & numerical data; D010360:Patient Transfer / Q000706:statistics & numerical data; D062645:Percutaneous Coronary Intervention / Q000706:statistics & numerical data; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011785:Quality Assurance, Health Care; D012042:Registries; D012307:Risk Factors; D012737:Sex Factors; D015912:Thrombolytic Therapy / Q000706:statistics & numerical data
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors